Abstract:Abstract Predicting the prognosis of pancreatic cancer is important because of the very low survival rates of patients with this particular cancer. Although several studies have used microRNA and gene expression profiles and clinical data, as well as images of tissues and cells, to predict cancer survival and recurrence, the accuracies of these approaches in the prediction of high-risk pancreatic adenocarcinoma (PAAD) still need to be improved. Accordingly, in this study, we proposed two biological features based on multi-omics datasets to predict survival and recurrence among patients with PAAD. First, the clonal expansion of cancer cells with somatic mutations was used to predict prognosis. Using whole-exome sequencing data from 134 patients with PAAD from The Cancer Genome Atlas (TCGA), we found five candidate genes that were mutated in the early stages of tumorigenesis with high cellular prevalence (CP). CDKN2A, TP53, TTN, KCNJ18, and KRAS had the highest CP values among the patients with PAAD, and survival and recurrence rates were significantly different between the patients harboring mutations in these candidate genes and those harboring mutations in other genes ( p = 2.39E−03, p = 8.47E−04, respectively). Second, we generated an autoencoder to integrate the RNA sequencing, microRNA sequencing, and DNA methylation data from 134 patients with PAAD from TCGA. The autoencoder robustly reduced the dimensions of these multi-omics data, and the K-means clustering method was then used to cluster the patients into two subgroups. The subgroups of patients had significant differences in survival and recurrence ( p = 1.41E−03, p = 4.43E−04, respectively). Finally, we developed a prediction model for prognosis using these two biological features and clinical data. When support vector machines, random forest, logistic regression, and L2 regularized logistic regression were used as prediction models, logistic regression analysis generally revealed the best performance for both disease-free survival (DFS) and overall survival (OS) (accuracy [ACC] = 0.762 and area under the curve [AUC] = 0.795 for DFS; ACC = 0.776 and AUC = 0.769 for OS). Thus, we could classify patients with a high probability of recurrence and at a high risk of poor outcomes. Our study provides insights into new personalized therapies on the basis of mutation status and multi-omics data.

An Unsupervised Deep Learning-Based Model Using Multiomics Data to Predict Prognosis of Patients with Stomach Adenocarcinoma

A Multi-Gene Model Effectively Predicts the Overall Prognosis of Stomach Adenocarcinomas with Large Genetic Heterogeneity Using Somatic Mutation Features.

LUADpp: an Effective Prediction Model on Prognosis of Lung Adenocarcinomas Based on Somatic Mutational Features

Multi-omics with Dynamic Network Biomarker Algorithm Prefigures Organ-Specific Metastasis of Lung Adenocarcinoma

Integrating multi-omics data through deep learning for accurate cancer prognosis prediction

Construction of Prognostic Risk Model for Patients with Colon Adenocarcinoma Based on Immunogenomics Analysis

Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data

A Model for Predicting Prognosis in Patients with Esophageal Squamous Cell Carcinoma Based on Joint Representation Learning

Survival Prediction of Stomach Cancer Using Expression Data and Deep Learning Models with Histopathological Images

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma

A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies

Pancancer survival prediction using a deep learning architecture with multimodal representation and integration

Autosurv: interpretable deep learning framework for cancer survival analysis incorporating clinical and multi-omics data

Deep-learning Model for Predicting the Survival of Rectal Adenocarcinoma Patients Based on a Surveillance, Epidemiology, and End Results Analysis

Prognosis Prediction of High Grade Serous Adenocarcinoma Based on Multi-Modal Convolution Neural Network

Stacked Autoencoder Based Multi-Omics Data Integration for Cancer Survival Prediction

Synergistic Effects of Different Levels of Genomic Data for the Staging of Lung Adenocarcinoma: An Illustrative Study

A Deep Learning-Based Multi-Model Ensemble Method for Cancer Prediction.

Predicting lung adenocarcinoma disease progression using methylation-correlated blocks and ensemble machine learning classifiers

A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma